ANIXA BIOSCIENCES, INC. Increase (Decrease) in Operating Assets
ANIXA BIOSCIENCES, INC. (ANIX) reported Increase (Decrease) in Operating Assets of $1.31 million for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingAssets · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. increase (decrease) in operating assets for the quarter ending 2026-07-31 was -$178.00K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in operating assets for the quarter ending 2026-04-30 was $516.00K, a 68.75% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in operating assets for the quarter ending 2026-01-31 was $972.00K, a 63.68% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in operating assets for the quarter ending 2025-07-31 was -$432.00K.
| Period end | Increase (Decrease) in Operating Assets 3 month | Increase (Decrease) in Operating Assets 6 month | Increase (Decrease) in Operating Assets 9 month |
|---|---|---|---|
| 2026-07-31 | -$178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $338.00K derived: sum of 2 quarters · filed 2026-09-09 | $1.31M 10-Q · filed 2026-09-09 |
| 2026-04-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $1.49M 10-Q · filed 2026-06-10 | |
| 2026-01-31 | $972.00K 10-Q · filed 2026-03-09 | ||
| 2025-07-31 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | $1.22M derived: sum of 2 quarters · filed 2025-09-10 | $3.90M 10-Q · filed 2025-09-10 |
| 2025-04-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | $4.33M 10-Q · filed 2025-05-28 | |
| 2025-01-31 | $2.68M 10-Q · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |